Prime time for doxorubicin-induced cardiotoxicity genetic testing

Pharmacogenomics. 2022 Apr;23(6):335-338. doi: 10.2217/pgs-2022-0032. Epub 2022 Apr 5.
No abstract available

Keywords: cardiotoxicity; chemotherapy; clinical translation; human-induced pluripotent stem cells; pharmacogenomics.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibiotics, Antineoplastic
  • Cardiotoxicity* / genetics
  • Doxorubicin / adverse effects
  • Genetic Testing
  • Humans
  • Induced Pluripotent Stem Cells*
  • Myocytes, Cardiac

Substances

  • Antibiotics, Antineoplastic
  • Doxorubicin